Back to search

Article

When Guidelines Meet Reality: The Combined Impact of Assay Variability and Prescribing Differences on TSH Management in Thyroid Cancer

2025-11-04

Abstract excerpt

<h4>Background: </h4> /Objectives: Patients with differentiated thyroid cancer (DTC) receive thyroxine substitution targeting thyroid-stimulating hormone (TSH) levels adapted to their response-to-treatment category. However, variations in prescription and TSH inter-assay variability may result in over- or undertreatment. <h4>Methods:</h4> We measured TSH in 220 consecutive DTC patients using three automated immuno...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6d43038a-9732-5799-be9d-9bdaf7b3f281
DOI
10.20944/preprints202511.0174.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
When Guidelines Meet Reality: The Combined Impact of Assay Variability and Prescribing Differences on TSH Management in Thyroid CancerDOI 10.20944/preprints202511.0174.v1
Select a neighboring publication to make it the new centre.